Brenntag delivers strong Q2 2026 financial results as EBITDA surges 41%
Brenntag attributed the performance to coordinated pricing strategies and effective stocking decisions in North America and Europe, the Middle East and Africa.
GERMANY – Brenntag SE, the global market leader in chemicals and ingredients distribution, reported a sharp acceleration in earnings for the second quarter of 2026, driven by disciplined commercial execution, dynamic pricing strategies, and structural efficiency gains.
Group sales rose 11% year-on-year to reach €4.26 billion (US$4.93B), up from €3.87 billion (US$4.48B) in Q2 2025.
Operating EBITDA surged 41% to €463 million (US$535.69M), while operating gross profit surged 19% to €1.15 billion (US$1.33B), reflecting a significant expansion in gross margin to 26.9%.
Profit after tax jumped to €182 million (US$210.57M), yielding an earnings per share of €1.23 (US$1.42) compared to €0.30 (US$0.35) in the prior-year period.
Group CEO Jens Birgersson said the quarter marked a shift from a first quarter that had been driven primarily by market volatility, with Q2 results increasingly reflecting the company’s own commercial initiatives, including customer penetration, cross-selling, upselling, pricing discipline and organizational simplification.
Divisional performance
Brenntag Essentials reported operating gross profit of €836 million (US$967.25M), up 23.1%, with gross margins expanding to 28.5%, a 2.2%-point gain, as North America and EMEA capitalized on unified pricing strategies and stocking decisions.
Brenntag Specialties delivered an 8.8% increase in operating gross profit to €310 million (US$358.67M) and an 18% rise in operating EBITDA to €130 million (US$150.41M).
Within Specialties, Life Science saw solid growth while Material Science delivered a standout result, with operating EBITDA jumping 71% to €51 million (US$59.01M).
On working capital, the company’s ongoing organizational transformation and cost-out initiative yielded €41 million (US$47.44 M) in gross cost savings during the second quarter, up from €27 million (US$31.24 M) in Q1 2026, keeping Brenntag on track to achieve its full-year cost-reduction target of approximately €150 million (US$173.55M).
Free cash flow fell to €4 million (US$4.63M) from €154 million (US$178.18 M) in the prior-year period, a decline management characterized as technical, linked to higher working-capital requirements from sales growth, seasonality and higher inventory valuations.
Chief Financial Officer Thomas Reisten said the cost-out program contributed €41 million (US$47.44M) in savings during the quarter and is tracking in line with full-year targets, adding that Brenntag’s financial position remains robust, providing the operational and financial flexibility to pursue disciplined, value-accretive bolt-on M&A.
Outlook 2026
Encouraged by sustained momentum entering the second half of the year, Brenntag raised its full-year 2026 operating EBITDA guidance to between €1.35 billion (US$1.56B) and €1.45 billion (US$1.68B), up from its previous projection of €1.25 billion (US$1.45B) to €1.40 billion (US$1.62B).
The company is targeting approximately €150 million (US $173.55M) in gross savings in 2026 and cumulative savings of €200 million (US$231.40M) to €250 million (US$289.25M) by 2027, following a rebasing of the program to fiscal 2025, with the program focused on organizational simplification, central-cost optimization and tighter management of discretionary spending.
Sign up to HERE receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on our WhatsApp channel for updates.
